Global Molecular Diagnostics Market Report: 2015 Edition
Molecular diagnostics is a dynamic and transformative area of diagnostics, leading to insights in research and treatment in many disease states that are revolutionizing health care. Molecular diagnostics detects and measures the presence of genetic material or proteins associated with a specific health condition or disease, helping to uncover the underlying mechanisms of disease and enabling clinicians to tailor care at an individual level facilitating the practice of personalized medicine.
Molecular diagnostics today is routinely used in hospitals, reference labs, and blood banks. In the latter, molecular tests are used to screen donated blood products for infectious diseases like hepatitis and HIV. In hospitals, testing is often performed to identify pathogens in patients with infections. In fact, infectious diseases are one of the strongest growing areas within the molecular diagnostics field. There is also increasing demand for such technologies at the point of care.
The report “Global Molecular Diagnostics Market” provides an in-depth analysis of the molecular diagnostics market along with a detailed study of its various segments. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The four major players in the industry, Roche Holding AG, Qiagen NV, Abbott Laboratories and Novartis are being profiled.
The key factors driving the growth of the molecular diagnostics industry are rising incidence of chronic and infectious disease, rising awareness and acceptance of personalized medicine, expansion in emerging countries, ageing population and technological developments. Some of the noteworthy trend and developments of this industry are growth of next generation sequencing and growth in point of care diagnostics. However, the expansion of global molecular diagnostics industry is hindered by challenges in genetic diagnostics and regulatory issues.
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
Molecular diagnostics today is routinely used in hospitals, reference labs, and blood banks. In the latter, molecular tests are used to screen donated blood products for infectious diseases like hepatitis and HIV. In hospitals, testing is often performed to identify pathogens in patients with infections. In fact, infectious diseases are one of the strongest growing areas within the molecular diagnostics field. There is also increasing demand for such technologies at the point of care.
The report “Global Molecular Diagnostics Market” provides an in-depth analysis of the molecular diagnostics market along with a detailed study of its various segments. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The four major players in the industry, Roche Holding AG, Qiagen NV, Abbott Laboratories and Novartis are being profiled.
The key factors driving the growth of the molecular diagnostics industry are rising incidence of chronic and infectious disease, rising awareness and acceptance of personalized medicine, expansion in emerging countries, ageing population and technological developments. Some of the noteworthy trend and developments of this industry are growth of next generation sequencing and growth in point of care diagnostics. However, the expansion of global molecular diagnostics industry is hindered by challenges in genetic diagnostics and regulatory issues.
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
1. DIAGNOSTICS: AN OVERVIEW
1.1 In Vitro Diagnostics
1.2 Molecular Diagnostics
2. DIAGNOSTICS MARKET
2.1 Global In Vitro Diagnostics (IVD) Market
Market Value
Market Segmentation
2.2 Global Molecular Diagnostics Market
Market Value
Market Segmentation
2.2.1 Human Papilloma Virus (HPV)
Global Market Value
Global Market Volume
2.2.2 CT/NG
Global Market Value
Global Market Volume
2.2.3 Global Genetic Testing Market
Global Market Value
3. MARKET DYNAMICS
3.1 Industry Trends and Developments
3.1.1 Growth of Next Generation Sequencing (NGS)
3.1.2 Growth in Point of Care Diagnostics
3.1.3 Growth in Non Invasive Prenatal Testing (NIPT)
3.2 Growth Drivers
3.2.1 Rising Incidence of Chronic and Infectious Diseases
3.2.2 Technological Developments
3.2.3 Rising Awareness and Acceptance of Personalized Medicine
3.2.4 Economic Growth
3.2.5 Expansion in Emerging Countries
3.2.6 Ageing Population Worldwide
3.2.7 Rising Healthcare Expenditure
3.3 Issues and Challenges
3.3.1 Challenges in Genetic Diagnostics
3.3.2 Regulatory Issues
4. COMPETITIVE LANDSCAPE
Molecular Diagnostics Market Share
CT/NG Market Share
HPV Market Share
5. COMPANY PROFILES
5.1 Roche Holding AG
5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategies
5.2 Qiagen NV
5.2.1 Business Overview
5.2.2 Financial Overview
5.2.3 Business Strategies
5.3 Abbott Laboratories
5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Business Strategies
5.4 Novartis
5.4.1 Business Overview
5.4.2 Financial Overview
5.4.3 Business Strategies
6. MARKET OUTLOOK
6.1 Market Forecast
6.2 Forecast Methodology
6.2.1 Dependent and Independent Variables
6.2.2 Correlation Analysis
6.2.3 Regression Analysis
1.1 In Vitro Diagnostics
1.2 Molecular Diagnostics
2. DIAGNOSTICS MARKET
2.1 Global In Vitro Diagnostics (IVD) Market
Market Value
Market Segmentation
2.2 Global Molecular Diagnostics Market
Market Value
Market Segmentation
2.2.1 Human Papilloma Virus (HPV)
Global Market Value
Global Market Volume
2.2.2 CT/NG
Global Market Value
Global Market Volume
2.2.3 Global Genetic Testing Market
Global Market Value
3. MARKET DYNAMICS
3.1 Industry Trends and Developments
3.1.1 Growth of Next Generation Sequencing (NGS)
3.1.2 Growth in Point of Care Diagnostics
3.1.3 Growth in Non Invasive Prenatal Testing (NIPT)
3.2 Growth Drivers
3.2.1 Rising Incidence of Chronic and Infectious Diseases
3.2.2 Technological Developments
3.2.3 Rising Awareness and Acceptance of Personalized Medicine
3.2.4 Economic Growth
3.2.5 Expansion in Emerging Countries
3.2.6 Ageing Population Worldwide
3.2.7 Rising Healthcare Expenditure
3.3 Issues and Challenges
3.3.1 Challenges in Genetic Diagnostics
3.3.2 Regulatory Issues
4. COMPETITIVE LANDSCAPE
Molecular Diagnostics Market Share
CT/NG Market Share
HPV Market Share
5. COMPANY PROFILES
5.1 Roche Holding AG
5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategies
5.2 Qiagen NV
5.2.1 Business Overview
5.2.2 Financial Overview
5.2.3 Business Strategies
5.3 Abbott Laboratories
5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Business Strategies
5.4 Novartis
5.4.1 Business Overview
5.4.2 Financial Overview
5.4.3 Business Strategies
6. MARKET OUTLOOK
6.1 Market Forecast
6.2 Forecast Methodology
6.2.1 Dependent and Independent Variables
6.2.2 Correlation Analysis
6.2.3 Regression Analysis
LIST OF CHARTS
IVD Market – Segments by Technology
Molecular Diagnostics – Traditional Process
Main Purposes of Molecular Diagnostics
IVD Market by Product Segments (2014)
Global IVD Market (2011 2016E)
Global IVD Market Share by Segment (2014)
Global Molecular Diagnostics Market (2009 2014)
Molecular Diagnostics Market Share by Segment (2014)
Molecular Diagnostics Market Share by Test Type (2014)
Global HPV Market by Value (2010 2014)
Global HPV Market by Volume (2010 2014)
Global CT/NG Market by Value (2011 2015E)
Global CT/NG Market by Volume (2011 2015E)
Global Genetic Testing Market (2007 2014)
Global GDP (2006 2013)
Global Ageing Population (2006 2014)
Global Healthcare Spending (2005 2014)
Global Molecular Diagnostic Market Share by Company (2014)
Global IVD Market Share by Company (2014E)
Global CT/NG Market Share by Company (2014)
Global HPV Market Share by Company (2014)
Roche’s Revenues by Business Segments (2014)
Share of Diagnostics’ Revenues by Sub Segments, Roche (2014)
Roche’s Net Sales and Net Income (2010 2014)
Qiagen’s Revenue Share by Customer Classes Served (2014)
Qiagen’s Revenue Share by Region (2014)
Qiagen’s Net Sales and Net Income (2010 2014)
Abbott Laboratories Revenue Share by Segments (2014)
Abbott Laboratories Revenue and Net Income (2010 2014)
Novartis’ Revenue Share by Business Segments (2014)
Novartis’ Net Sales and Net Income (2010 2014)
Global Molecular Diagnostics Market Forecast (2014 2018E)
IVD Market – Segments by Technology
Molecular Diagnostics – Traditional Process
Main Purposes of Molecular Diagnostics
IVD Market by Product Segments (2014)
Global IVD Market (2011 2016E)
Global IVD Market Share by Segment (2014)
Global Molecular Diagnostics Market (2009 2014)
Molecular Diagnostics Market Share by Segment (2014)
Molecular Diagnostics Market Share by Test Type (2014)
Global HPV Market by Value (2010 2014)
Global HPV Market by Volume (2010 2014)
Global CT/NG Market by Value (2011 2015E)
Global CT/NG Market by Volume (2011 2015E)
Global Genetic Testing Market (2007 2014)
Global GDP (2006 2013)
Global Ageing Population (2006 2014)
Global Healthcare Spending (2005 2014)
Global Molecular Diagnostic Market Share by Company (2014)
Global IVD Market Share by Company (2014E)
Global CT/NG Market Share by Company (2014)
Global HPV Market Share by Company (2014)
Roche’s Revenues by Business Segments (2014)
Share of Diagnostics’ Revenues by Sub Segments, Roche (2014)
Roche’s Net Sales and Net Income (2010 2014)
Qiagen’s Revenue Share by Customer Classes Served (2014)
Qiagen’s Revenue Share by Region (2014)
Qiagen’s Net Sales and Net Income (2010 2014)
Abbott Laboratories Revenue Share by Segments (2014)
Abbott Laboratories Revenue and Net Income (2010 2014)
Novartis’ Revenue Share by Business Segments (2014)
Novartis’ Net Sales and Net Income (2010 2014)
Global Molecular Diagnostics Market Forecast (2014 2018E)
LIST OF TABLES
Financial Comparison of Key Players (2014)
Dependent & Independent Variables (2009 2014)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output
Financial Comparison of Key Players (2014)
Dependent & Independent Variables (2009 2014)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output
